A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial

BACKGROUND: Depressive symptoms are usually managed within primary care and antidepressant medication constitutes the first-line treatment. It remains unclear at present which people are more likely to benefit from antidepressant medication. This paper describes the protocol for a randomised control...

Descripción completa

Detalles Bibliográficos
Autores principales: Salaminios, George, Duffy, Larisa, Ades, Anthony, Araya, Ricardo, Button, Katherine S., Churchill, Rachel, Croudace, Tim, Derrick, Catherine, Dixon, Padraig, Dowrick, Christopher, Gilbody, Simon, Hollingworth, William, Jones, Vivien, Kendrick, Tony, Kessler, David, Kounali, Daphne, Lanham, Paul, Malpass, Alice, Peters, Tim J., Riozzie, Derek, Robinson, Jude, Sharp, Debbie, Thomas, Laura, Welton, Nicky J., Wiles, Nicola, Lewis, Glyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655852/
https://www.ncbi.nlm.nih.gov/pubmed/29065916
http://dx.doi.org/10.1186/s13063-017-2253-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655852/
https://www.ncbi.nlm.nih.gov/pubmed/29065916
http://dx.doi.org/10.1186/s13063-017-2253-4

Ejemplares similares